LIVN Insider Trading

Insider Ownership Percentage: 0.27%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,467,346.03

LivaNova Insider Trading History Chart

This chart shows the insider buying and selling history at LivaNova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal Insider BuyingTotal Insider Selling

LivaNova Share Price & Price History

Current Price: $37.51
Price Change: Price Increase of +0.25 (0.67%)
As of 04/28/2025 05:00 PM ET

This chart shows the closing price history over time for LIVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$37.51Closing price on 04/28/25:

LivaNova Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for LivaNova (NASDAQ:LIVN)

97.64% of LivaNova stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LIVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.73Mbought$21MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
LivaNova logo
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Read More on LivaNova

Today's Range

Now: $37.51
Low: $36.94
High: $37.74

50 Day Range

MA: $38.74
Low: $33.85
High: $49.50

52 Week Range

Now: $37.51
Low: $32.48
High: $64.48

Volume

507,015 shs

Average Volume

620,686 shs

Market Capitalization

$2.04 billion

P/E Ratio

89.31

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of LivaNova?

LivaNova's top insider investors include:
  1. Daniel Jeffrey Moore (Director)
  2. Francesco Bianchi (Director)
Learn More about top insider investors at LivaNova.

Who are the major institutional investors of LivaNova?

LivaNova's top institutional shareholders include:
  1. Allspring Global Investments Holdings LLC — 0.53%
  2. Principal Financial Group Inc. — 0.33%
  3. Rhumbline Advisers — 0.32%
  4. Harbor Capital Advisors Inc. — 0.16%
  5. KBC Group NV — 0.08%
  6. Amalgamated Bank — 0.04%
Learn More about top institutional investors of LivaNova stock.

Which major investors are selling LivaNova stock?

Within the last quarter, LIVN stock was sold by these institutional investors:
  1. Allspring Global Investments Holdings LLC
  2. KBC Group NV
  3. Teacher Retirement System of Texas
  4. Rhumbline Advisers
  5. Amalgamated Bank
  6. Yousif Capital Management LLC
During the last year, company insiders that have sold LivaNova company stock include:
  1. Daniel Jeffrey Moore (Director)
  2. Francesco Bianchi (Director)
Learn More investors selling LivaNova stock.

Which major investors are buying LivaNova stock?

Within the last quarter, LIVN stock was purchased by institutional investors including:
  1. Harbor Capital Advisors Inc.
  2. Chapin Davis Inc.
  3. GAMMA Investing LLC
  4. Principal Financial Group Inc.
  5. UMB Bank n.a.
  6. Central Pacific Bank Trust Division